INNOVATE
Setting up an R&D project
Lyonbiopole supports you to set-up your R&D projects
The accreditation by Lyonbiopole is a quality recognition of your project by well-known experts and members of the cluster’s governance. The suitability of your project with Lyonbiopole’s theme is the prerequisite for requesting a accreditation.
The themes are: infectious diseases, cancer, virology, bacteriology, parasitology, mycology, immunology, immunology and immune disorders including autoimmune, inflammatory and orphans diseases,
The cluster’s themes – Download (PDF)
If your project falls within the domains and thematic quoted, Lyonbiopole offers you to accredit your project and maximizes your chances of obtaining funding.
The acccreditation goals :
1> Develop partnerships by strengthening public / private collaborations
2> Make requests for funding R&D projects
3> Strengthen and coordinate research on the cluster’s themes
4> Promote economic development in the cluster’s territory
Accreditation proceeds in four steps :
1> Applicate by completing the intent project R&D Letter (download it on the page of the call you have selected) and sending it to the Lyonbiopole’s Scientific Director
2> Writing of a position paper with the Scientific Director’s advice on the project, sent to the Technical Group
3> Evaluation of the application by the Technical Group
4> Final draft accredited by the Board of Directors
Five main eligibility criterias are taken into account when accrediting:
1> The project's consistency with the cluster’s themes and priorities
2> Adequacy with the eligibility requirements for the nature of the call for projects
3> Geographical location of partners
4> The project’s maturity (industrial property at startup, goals, phasing, partnership, completed financing plan)
5> Impact on the economic and technological development center: investment, employment ...
They speak about...
« Innovations by biotech firms still take too long to reach major pharmaceutical companies, despite the growing needs of industrial firms and their interest in these breakthroughs in the area of personalized treatment. One of the main reasons is that start ups lack networks and visibility in the eyes of these large industrial groups. These two complementary players thus need a catalyst to create meetings, pass on information and contact one another. This is what World Competitive Clusters like Lyonbiopole do. ImmunID has benefited from this effective support, and we have had excellent results in 2008 and 2009, signing contracts with several firms which are leaders in their field, such as Sanofi Pasteur. In the end, Lyonbiopole is an organization which plays an active role in setting up and giving impetus to future high potential R&D projects in the health sphere. »
Nicolas Pasqual
ImmunID Technologies - Ph.D. CEO